Robert S. Cabral

Array ( [id] => 19550209 [patent_doc_number] => 12133901 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-11-05 [patent_title] => PSMA ligand targeted compounds and uses thereof [patent_app_type] => utility [patent_app_number] => 17/424084 [patent_app_country] => US [patent_app_date] => 2020-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 12343 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17424084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17546562 [patent_doc_number] => 20220117903 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-21 [patent_title] => DRUG DELIVERY SYSTEM AND METHOD [patent_app_type] => utility [patent_app_number] => 17/422414 [patent_app_country] => US [patent_app_date] => 2020-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4157 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17422414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17966996 [patent_doc_number] => 11484500 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-01 [patent_title] => Hybridosomes, compositions comprising the same, processes for their production and uses thereof [patent_app_type] => utility [patent_app_number] => 16/732567 [patent_app_country] => US [patent_app_date] => 2020-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 27 [patent_no_of_words] => 22293 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16732567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15863097 [patent_doc_number] => 20200138952 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-07 [patent_title] => SODIUM CHLORIDE SOLUTION FOR DRUG RECONSTITUTION OR DILUTION [patent_app_type] => utility [patent_app_number] => 16/723563 [patent_app_country] => US [patent_app_date] => 2019-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11951 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16723563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15990605 [patent_doc_number] => 20200171173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-04 [patent_title] => MODIFIED-DEXTRANS FOR USE IN OPTICAL GLUCOSE ASSAYS [patent_app_type] => utility [patent_app_number] => 16/720299 [patent_app_country] => US [patent_app_date] => 2019-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8160 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16720299 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17783501 [patent_doc_number] => 11406603 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-09 [patent_title] => Multisomes: encapsulated droplet networks [patent_app_type] => utility [patent_app_number] => 16/721302 [patent_app_country] => US [patent_app_date] => 2019-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 16 [patent_no_of_words] => 29447 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 207 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16721302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15912827 [patent_doc_number] => 10653634 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2020-05-19 [patent_title] => Polymeric nanoparticulate formulation to enhance the oral bioavailability of dapoxetine [patent_app_type] => utility [patent_app_number] => 16/719248 [patent_app_country] => US [patent_app_date] => 2019-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 20 [patent_no_of_words] => 9836 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16719248 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16548470 [patent_doc_number] => 10881607 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-01-05 [patent_title] => Composition for transdermal delivery of cationic active agents [patent_app_type] => utility [patent_app_number] => 16/715972 [patent_app_country] => US [patent_app_date] => 2019-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7276 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 271 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16715972 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17814365 [patent_doc_number] => 11419955 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-23 [patent_title] => Multimodal silica-based nanoparticles [patent_app_type] => utility [patent_app_number] => 16/714182 [patent_app_country] => US [patent_app_date] => 2019-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 60 [patent_figures_cnt] => 187 [patent_no_of_words] => 44846 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16714182 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19354304 [patent_doc_number] => 12054735 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-08-06 [patent_title] => Viral vector production system [patent_app_type] => utility [patent_app_number] => 16/714516 [patent_app_country] => US [patent_app_date] => 2019-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 56 [patent_no_of_words] => 47121 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16714516 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16572187 [patent_doc_number] => 10894098 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-01-19 [patent_title] => Methods and compositions for targeted imaging [patent_app_type] => utility [patent_app_number] => 16/712215 [patent_app_country] => US [patent_app_date] => 2019-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 49337 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16712215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15768979 [patent_doc_number] => 20200115507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-16 [patent_title] => SHAPE-PRESERVING POLYMERIC REPLICATION OF BIOLOGICAL MATTER [patent_app_type] => utility [patent_app_number] => 16/711150 [patent_app_country] => US [patent_app_date] => 2019-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17506 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16711150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17370133 [patent_doc_number] => 20220025185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-27 [patent_title] => SPECIFICALLY GLYCO-SUBSTITUTED PORPHYRINS AND CHLORINS FOR PHOTODYNAMIC THERAPY [patent_app_type] => utility [patent_app_number] => 17/312315 [patent_app_country] => US [patent_app_date] => 2019-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11928 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 514 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17312315 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15742393 [patent_doc_number] => 20200110085 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-09 [patent_title] => SYSTEM AND APPARATUS FOR POROUSLY-ENCAPSULATED MAGNETIC-NANOPARTICLE BIOSENSORS [patent_app_type] => utility [patent_app_number] => 16/708302 [patent_app_country] => US [patent_app_date] => 2019-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5524 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 212 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16708302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18852692 [patent_doc_number] => 11850244 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-12-26 [patent_title] => Drug delivery systems and methods for treatment of bladder dysfunction or disorder using trospium [patent_app_type] => utility [patent_app_number] => 16/706009 [patent_app_country] => US [patent_app_date] => 2019-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 18 [patent_no_of_words] => 6897 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16706009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18871172 [patent_doc_number] => 11858958 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-01-02 [patent_title] => Blank liposome with ginsenoside Rg3 or its analog as membrane materials and preparations and uses thereof [patent_app_type] => utility [patent_app_number] => 16/961899 [patent_app_country] => US [patent_app_date] => 2019-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 15 [patent_no_of_words] => 16665 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16961899 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17384017 [patent_doc_number] => 20220031869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-03 [patent_title] => NANOCARRIER SYSTEMS FOR IMAGING AND DELIVERY OF ACTIVE AGENTS [patent_app_type] => utility [patent_app_number] => 17/296379 [patent_app_country] => US [patent_app_date] => 2019-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16416 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17296379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18134361 [patent_doc_number] => 11560014 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-01-24 [patent_title] => Nanostructured surfaces [patent_app_type] => utility [patent_app_number] => 16/692744 [patent_app_country] => US [patent_app_date] => 2019-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 45 [patent_no_of_words] => 8083 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 215 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16692744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16229314 [patent_doc_number] => 10736843 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2020-08-11 [patent_title] => In situ gelling composition containing tocopherol-loaded micelles as an intranasal drug delivery system [patent_app_type] => utility [patent_app_number] => 16/691678 [patent_app_country] => US [patent_app_date] => 2019-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 10696 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16691678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17342240 [patent_doc_number] => 20220008571 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-13 [patent_title] => RECONSTITUTED HDL NANOPARTICLES FOR DELIVERY OF RADIOACTIVE AGENTS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/294701 [patent_app_country] => US [patent_app_date] => 2019-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9497 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17294701 [rel_patent_id] =>[rel_patent_doc_number] =>)